A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 143 participants.

Also called NCT02452632

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 143 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02452632
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02452632. Randomized; quadruple masking; primary purpose treatment. Start 2015-06-22 (actual); primary completion 2017-01-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
ASP1941
Intervention (Drug)
Placebo
Lead sponsor
Astellas Pharma Korea, Inc. (class: industry)

Record details

Record id
cardio:ct-nct02452632
Content hash
62e6bae88ab2a56c7303cadc31811e1501253e80a6a105d68094d56e1dbac80a